Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Submitted by
admin
on May 24, 2023 - 11:18am
Source:
Motley Fool
News Tags:
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Headline:
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
snippet:
There isn't much overlap between Amgen's business and Horizons', but that isn't stopping the FTC from looking to block the deal.
Pfizer has a strong oncology portfolio and is planning to acquire Seagen, a company with an entire focus on cancer treatments.
Pfizer's deal is much larger than the Amgen-Horizons acquisition.
Do Not Allow Advertisers to Use My Personal information
